Zhang JH, Zhang XY, Sun YQ, et al. Metformin used is associated with a reduced risk of cognitive impairment in adults with diabetes mellitus: A systematic review and meta-analysis. Front Neurosci 2022;16:984559
Cao F, Yang F, Li J, et al. The relationship between diabetes and the dementia risk: a meta-analysis. Diabetol Metab Syndr 2024;16:101
Pawlos A, Broncel M, Wozniak E, et al. Neuroprotective effect of SGLT inhibitors. Molecules 2021;26:7213
Shin A, Koo BK, Lee JY, et al. Risk of dementia after initiation of sodium-glucose co-transporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40-69 years with type 2 diabetes: population based cohort study. BMJ 2024;386:e079475
Kumari K, Bai A, Geeta F, et al. Risk of dementia in patients with type 2 diabetes using SGLT2 inhibitors versus DPP-4 inhibitors: a systematic review and meta-analysis. Endocrinol Diabetes Metab 2026;9:e70174
健康網購
